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Résumé en
anglais
Amyotrophic lateral sclerosis (ALS) is characterized by a wide metabolic remodeling,
as shown by recent metabolomics and lipidomics studies performed in samples from
patient cohorts and experimental animal models. Here, we explored the metabolome
and lipidome of fibroblasts from sporadic ALS patients (n = 13) comparatively to age-
and sex-matched controls (n = 11), and the subcellular fraction containing the
mitochondria and endoplasmic reticulum (mito-ER), given that mitochondrial
dysfunctions and ER stress are important features of ALS patho-mechanisms. We also
assessed the mitochondrial oxidative respiration and the mitochondrial genomic
(mtDNA) sequence, although without yielding significant differences. Compared to
controls, ALS fibroblasts did not exhibit a mitochondrial respiration defect nor an
increased proportion of mitochondrial DNA mutations. In addition, non-targeted
metabolomics and lipidomics analyses identified 124 and 127 metabolites, and 328
and 220 lipids in whole cells and the mito-ER fractions, respectively, along with
partial least-squares-discriminant analysis (PLS-DA) models being systematically
highly predictive of the disease. The most discriminant metabolomic features were the
alteration of purine, pyrimidine, and energetic metabolisms, suggestive of oxidative
stress and of pro-inflammatory status. The most important lipidomic feature in the
mito-ER fraction was the disturbance of phosphatidylcholine PC (36:4p) levels, which
we had previously reported in the cerebrospinal fluid of ALS patients and in the brain
from an ALS mouse model. Thus, our results reveal that fibroblasts from sporadic ALS
patients share common metabolic remodeling, consistent with other metabolic studies
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